• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑钠肽前体和肌钙蛋白T超敏水平与肝硬化患者肝功能障碍的严重程度相关。

Pro-Brain Natriuretic Peptide and Troponin T-Hypersensitivity Levels Correlate With the Severity of Liver Dysfunction in Liver Cirrhosis.

作者信息

Zhao Jiancheng, Li Sai, Ren Linan, Guo Xiaozhong, Qi Xingshun

机构信息

Department of Gastroenterology (JZ, LR, XG, XQ), General Hospital of Shenyang Military Area, Shenyang, China; Department of Rehabilitation (JZ), Jia He Hospital of the Liaoning University of Traditional Chinese Medicine, Shenyang, China.

Department of Cardiology (SL), No. 4 People's Hospital of Shenyang City, Shenyang, China.

出版信息

Am J Med Sci. 2017 Aug;354(2):131-139. doi: 10.1016/j.amjms.2017.04.005. Epub 2017 Apr 7.

DOI:10.1016/j.amjms.2017.04.005
PMID:28864370
Abstract

BACKGROUND

Increased pro-brain natriuretic peptide (pro-BNP) or troponin T-hypersensitivity (TnT-HSST) levels are common in liver cirrhosis. We conducted a retrospective observational study aimed to evaluate the correlation of pro-BNP and TnT-HSST levels with the clinical characteristics, laboratory data and in-hospital outcomes of patients with liver cirrhosis.

MATERIALS AND METHODS

We selected cirrhotic patients admitted to our hospital between January 2011 and June 2014. All eligible patients had pro-BNP or TnT-HSST data, or both. The pro-BNP and TnT-HSST data were further divided according to the presence of cardiac diseases.

RESULTS

The prevalence of pro-BNP level >900pg/mL was 41.72% (63 of 151 patients). The prevalence of TnT-HSST level >0.05ng/mL was 11.22% (45 of 401 patients). In the overall analysis, pro-BNP level significantly correlated with red blood cell (RBC), platelet, ascites, blood urea nitrogen (BUN), creatinine (Cr), Child-Pugh score, model for end-stage liver disease (MELD) score and in-hospital death; TnT-HSST level significantly correlated with white blood cell, ascites, albumin (ALB), BUN, Cr, Child-Pugh score, MELD score and in-hospital death. In patients with cardiac diseases, pro-BNP level significantly correlated with RBC, ascites, BUN, Cr, Child-Pugh score and MELD score; TnT-HSST level significantly correlated with sex, ascites, white blood cell, ALB, BUN, Cr, Child-Pugh score, MELD score and in-hospital death. In patients without cardiac diseases, pro-BNP level significantly correlated with ascites, RBC, platelet, BUN, Cr, MELD score and in-hospital death; TnT-HSST level significantly correlated with age, ascites, RBC, ALB, BUN, Cr, Child-Pugh score, MELD score and in-hospital death.

CONCLUSIONS

Pro-BNP and TnT-HSST levels significantly correlated with the severity of liver dysfunction and in-hospital mortality in cirrhosis.

摘要

背景

在肝硬化患者中,脑钠肽前体(pro-BNP)水平升高或肌钙蛋白T超敏反应(TnT-HSST)水平升高较为常见。我们开展了一项回顾性观察性研究,旨在评估pro-BNP和TnT-HSST水平与肝硬化患者的临床特征、实验室数据及住院结局之间的相关性。

材料与方法

我们选取了2011年1月至2014年6月期间入住我院的肝硬化患者。所有符合条件的患者均有pro-BNP或TnT-HSST数据,或两者皆有。根据是否存在心脏疾病对pro-BNP和TnT-HSST数据进行进一步划分。

结果

pro-BNP水平>900pg/mL的患病率为41.72%(151例患者中的63例)。TnT-HSST水平>0.05ng/mL的患病率为11.22%(401例患者中的45例)。在总体分析中,pro-BNP水平与红细胞(RBC)、血小板、腹水、血尿素氮(BUN)、肌酐(Cr)、Child-Pugh评分、终末期肝病模型(MELD)评分及住院死亡显著相关;TnT-HSST水平与白细胞、腹水、白蛋白(ALB)、BUN、Cr、Child-Pugh评分、MELD评分及住院死亡显著相关。在有心脏疾病的患者中,pro-BNP水平与RBC、腹水、BUN、Cr、Child-Pugh评分及MELD评分显著相关;TnT-HSST水平与性别、腹水、白细胞、ALB、BUN、Cr、Child-Pugh评分、MELD评分及住院死亡显著相关。在无心脏疾病的患者中,pro-BNP水平与腹水、RBC、血小板、BUN、Cr、MELD评分及住院死亡显著相关;TnT-HSST水平与年龄、腹水、RBC、ALB、BUN、Cr、Child-Pugh评分、MELD评分及住院死亡显著相关。

结论

pro-BNP和TnT-HSST水平与肝硬化患者肝功能障碍的严重程度及住院死亡率显著相关。

相似文献

1
Pro-Brain Natriuretic Peptide and Troponin T-Hypersensitivity Levels Correlate With the Severity of Liver Dysfunction in Liver Cirrhosis.脑钠肽前体和肌钙蛋白T超敏水平与肝硬化患者肝功能障碍的严重程度相关。
Am J Med Sci. 2017 Aug;354(2):131-139. doi: 10.1016/j.amjms.2017.04.005. Epub 2017 Apr 7.
2
Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.肝硬化患者循环中前脑钠肽(proBNP)和脑钠肽(BNP)水平升高:与心血管功能障碍及疾病严重程度的关系
Gut. 2003 Oct;52(10):1511-7. doi: 10.1136/gut.52.10.1511.
3
Brain natriuretic peptide in decompensation of liver cirrhosis in non-cardiac patients.非心脏疾病患者肝硬化失代偿期的脑钠肽
Hepatogastroenterology. 2009 Jan-Feb;56(89):181-5.
4
Prevalence of cirrhotic cardiomyopathy and its relationship with serum pro-brain natriuretic peptide, hepatorenal syndrome, spontaneous bacterial peritonitis, and mortality.肝硬化心肌病的患病率及其与血清脑利钠肽前体、肝肾综合征、自发性细菌性腹膜炎和死亡率的关系。
Indian J Gastroenterol. 2020 Oct;39(5):481-486. doi: 10.1007/s12664-020-01083-2. Epub 2020 Nov 13.
5
Prevalence, Risk Factors and In-hospital Outcomes of QTc Interval Prolongation in Liver Cirrhosis.肝硬化患者QTc间期延长的患病率、危险因素及住院结局
Am J Med Sci. 2016 Sep;352(3):285-95. doi: 10.1016/j.amjms.2016.06.012. Epub 2016 Jun 28.
6
Highly sensitive cardiac troponin T in heart failure: comparison with echocardiographic parameters and natriuretic peptides.心力衰竭中心肌肌钙蛋白 T 的高灵敏度:与超声心动图参数和利钠肽的比较。
J Cardiol. 2012 Mar;59(2):202-8. doi: 10.1016/j.jjcc.2011.11.012. Epub 2012 Jan 21.
7
Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients.脑钠肽与非酒精性肝硬化患者的疾病严重程度
J Gastroenterol Hepatol. 2005 Jul;20(7):1115-20. doi: 10.1111/j.1440-1746.2005.03906.x.
8
B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis.B 型利钠肽与失代偿期肝硬化住院患者的心脏功能和预后相关。
Liver Int. 2010 Aug;30(7):1059-66. doi: 10.1111/j.1478-3231.2010.02266.x. Epub 2010 May 14.
9
Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study.白蛋白-胆红素评分预测肝硬化急性上消化道出血患者院内死亡率的回顾性研究
Turk J Gastroenterol. 2016 Mar;27(2):180-6. doi: 10.5152/tjg.2016.15502.
10
N-Terminal pro-B-Type Natriuretic Peptide Levels are Linked with Modified Child-Pugh Classification in Patients with Nonalcoholic Cirrhosis [NT-ProBNP and Liver Cirrhosis].N端前B型利钠肽水平与非酒精性肝硬化患者改良Child-Pugh分级相关[NT-ProBNP与肝硬化]
Cell Biochem Biophys. 2017 Mar;75(1):111-117. doi: 10.1007/s12013-016-0773-2. Epub 2016 Dec 2.

引用本文的文献

1
Crosstalk between cardiac dysfunction and outcome of liver cirrhosis: Perspectives from evidence-based medicine and holistic integrative medicine.心脏功能障碍与肝硬化结局之间的相互影响:基于循证医学和整体整合医学的观点
J Transl Int Med. 2025 May 8;13(2):93-96. doi: 10.1515/jtim-2025-0015. eCollection 2025 Apr.
2
Markers of cardiac injury in patients with liver cirrhosis.肝硬化患者的心脏损伤标志物。
Croat Med J. 2023 Oct 31;64(5):362-373. doi: 10.3325/cmj.2023.64.362.
3
B-type natriuretic peptide (BNP) predicts 90-day mortality and need for paracentesis in cirrhotic patients without systolic heart failure.
B型利钠肽(BNP)可预测无收缩性心力衰竭的肝硬化患者90天死亡率及腹腔穿刺需求。
Sci Rep. 2021 Jan 18;11(1):1697. doi: 10.1038/s41598-020-78946-3.
4
Correlation of Serum Cardiac Markers with Acute Decompensating Events in Liver Cirrhosis.血清心脏标志物与肝硬化急性失代偿事件的相关性
Gastroenterol Res Pract. 2020 Sep 24;2020:4019289. doi: 10.1155/2020/4019289. eCollection 2020.
5
Preoperative high-sensitivity troponin I and B-type natriuretic peptide, alone and in combination, for risk stratification of mortality after liver transplantation.术前高敏肌钙蛋白 I 和 B 型利钠肽单独及联合用于肝移植术后死亡率的风险分层。
Korean J Anesthesiol. 2021 Jun;74(3):242-253. doi: 10.4097/kja.20296. Epub 2020 Aug 26.
6
Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension.经颈静脉肝内门体分流术治疗门静脉高压。
Gut. 2020 Jul;69(7):1173-1192. doi: 10.1136/gutjnl-2019-320221. Epub 2020 Feb 29.
7
The Confounding Effects of Non-cardiac Pathologies on the Interpretation of Cardiac Biomarkers.非心脏疾病对心脏生物标志物解读的混杂效应
Curr Heart Fail Rep. 2018 Aug;15(4):239-249. doi: 10.1007/s11897-018-0398-4.